The World Health Organization (WHO) has claimed that malaria can be eradicated with accelerated research and development (R&D), using new tools.

At present, less than 1% of global funding for health R&D investment goes to develop tools to eradicate the disease.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Furthermore, WHO flags the urgent need for progress to advance universal health coverage and improve access to services.

Better surveillance is also required to guide a more targeted malaria response, the organisation said.

WHO director-general Dr Tedros Adhanom Ghebreyesus said: “Freeing the world of malaria would be one of the greatest achievements in public health. With new tools and approaches, we can make this vision a reality.”

The latest findings in a report released by WHO’s Strategic Advisory Group on Malaria Eradication (SAGme) followed a three-year-long analysis of the global fight against the disease.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

SAGme chair Dr Marcel Tanner said: “To achieve a malaria-free world, we must reinvigorate the drive to find the transformative strategies and tools tailored to the local situation.”

Based on the group’s analyses, an additional two billion malaria cases and four million deaths can be prevented by 2030 by scaling up existing malaria interventions. The cost of this scale-up is estimated to be $34bn.

Some new strategic approaches are already being established by WHO and its partners to tackle malaria.

In November last year, WHO and the RBM Partnership to End Malaria launched the ‘High burden to high impact’ approach to jumpstart progress against malaria.

The partnership targeted its attention to the 11 countries that carry 70% of the world’s malaria burden.

WHO has certified 38 countries and territories malaria-free, until now.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact